3 recruiting, 1 active not recruiting, 1 completed. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Recruiting 3, Active not recruiting 1, Completed 1 |
Follow Respiratory Syncytial Virus (RSV): new trials by email Literature Review of Respiratory Syncytial Virus (RSV) trials Research Report on Respiratory Syncytial Virus (RSV)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunogenicity and Safety of Respiratory Syncytial Virus Vaccine in Lung Transplant Recipients RSVPreF3 vaccination - Vaccination, Respiratory Syncytial Virus (RSV) | Phase 4 | Recruiting | Seoul National University Hospital | 80 | 2026-10-01 | 2026-10-26 |
| THRIVE - Trial of Passive Humoral RSV Immunity for Value and Effectiveness Nirsevimab (RSV-specific monoclonal antibody) - Respiratory Syncytial Virus (RSV), Respiratory Infection Virus | Phase 4 | Recruiting | Menzies School of Health Research | 1000 | 2026-06-17 | 2026-10-07 |
| Systems Biological Analysis of Immune Responses to RSV Vaccine Moderna RSV vaccine - Respiratory Syncytial Virus (RSV) | Phase 4 | Active not recruiting | Emory University | 14 | 2025-10-13 | 2026-08-12 |
| Immunogenicity of RSV Vaccines in Residents of Long-Term Care Facilities (LTCF) RSV vaccine - Respiratory Syncytial Virus (RSV) | Phase 4 | Completed | University of Rochester | 152 | 2023-11-07 | 2025-10-27 |
| Antibiotic Therapy in Viral Airway Infections Stop antibiotic therapy - Infectious Disease, Influenza | Phase 4 | Recruiting | University Hospital, Akershus | 380 | 2022-01-13 | 2025-08-12 |
Communicable Diseases (1) · Influenza, Human (1) · Respiratory Tract Infections (1)
Disease Attributes (1) · Infections (1) · Orthomyxoviridae Infections (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · RNA Virus Infections (1) · Respiratory Tract Diseases (1) · Virus Diseases (1)
Respiratory Syncytial Virus Vaccines (1) · nirsevimab (1)
Emory University (1) · Menzies School of Health Research (1) · Seoul National University Hospital (1) · University Hospital, Akershus (1) · University of Rochester (1)
United States (2) · Australia (1) · Norway (1) · South Korea (1)
Ann Falsey (1) · Magnus N Lyngbakken, MD PhD (1) · Nadine Rouphael, MD (1) · Nam Joong Kim, M.D., PhD. (1)